🐜
|
Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children
20 auth.
J. Langley,
A. Carmona Martínez,
A. Chatterjee,
S. Halperin,
S. Mcneil,
K. Reisinger,
N. Aggarwal,
Li-Min Huang,
C. Peng,
J. Garcia-Sicilia,
...
Ignacio Salamanca de la Cueva,
F. Cabañas,
C. Treviño‐Garza,
M. A. Rodríguez-Weber,
Manuel de la O,
V. Chandrasekaran,
W. Dewé,
Aixue Liu,
B. Innis,
Varsha K. Jain
|
6 |
2013 |
6 🐜
|
🐜
|
Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons.
44 auth.
Carine Claeys,
K. Zaman,
G. Dbaibo,
Ping Li,
A. Izu,
P. Kosalaraksa,
Luis Rivera,
B. Acosta,
M. L. ARROBA BASANTA,
A. Aziz,
Miguel Angel Cabanero,
Vijayalakshmi Chandrashekaran,
B. Corsaro,
Luis Cousin,
Adolfo Diaz,
...
J. Díez-Domingo,
E. Dinleyici,
S. Faust,
D. Friel,
J. Garcia-Sicilia,
G. D. Gomez-Go,
Maria Liza Antoinette Gonzales,
S. Hughes,
T. Jackowska,
S. Kant,
M. Lucero,
Ludovic Malvaux,
J. Marés Bermúdez,
F. Martinón-Torres,
Mariano Miranda,
May Montellano,
Maria Amor Peix Sambola,
R. Prymula,
T. Puthanakit,
Renáta Růžková,
Iwona Sadowska-Krawczenko,
Ignacio Salamanca de la Cueva,
E. Sokal,
Jyoti Soni,
H. Szymański,
À. Ulied,
A. Schuind,
Varsha K. Jain,
B. Innis
|
5 |
2018 |
5 🐜
|
🐜
|
Factors influencing HPV knowledge and vaccine acceptability in parents of adolescent children: results from a survey-based study (KAPPAS study)
11 auth.
Noelia López,
Ignacio Salamanca de la Cueva,
Edelmiro Vergés,
E. Suárez Vicent,
A. Sánchez,
Ana Belén López,
...
María Belén Panizo-Santos,
María Garcés-Sánchez,
A. Montesdeoca,
Antonio José Rivera,
M. Cotarelo Suárez
|
4 |
2022 |
4 🐜
|
🐜
|
Brand-Specific Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season
11 auth.
Gael Dos Santos,
B. Nguyen,
Silvia Damaso,
L. Godderis,
X. Martínez-Gómez,
Tamara Eckermann,
...
Hugo Loos,
Ignacio Salamanca de la Cueva,
Vishvesh Shende,
Alexander Schmidt,
A. Yeakey
|
3 |
2019 |
3 🐜
|
🐬
|
A phase 1, open-label safety and immunogenicity study of an AS03-adjuvanted trivalent inactivated influenza vaccine in children aged 6 to 35 months
A. Carmona Martínez,
Ignacio Salamanca de la Cueva,
P. Boutet,
Carline Vanden Abeele,
I. Smolenov,
J. Devaster
|
3 |
2014 |
3 🐬
|
🦁
|
Safety Profile of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season
9 auth.
Ignacio Salamanca de la Cueva,
E. Cinconze,
Tamara Eckermann,
Ugochukwu Nwoji,
L. Godderis,
Emily Lu,
...
X. Martínez-Gómez,
Huajun Wang,
Emad Yanni
|
2 |
2021 |
2 🦁
|
🐜
|
[Bacterial etiology of acute otitis media in Spain in the post-pneumococcal conjugate vaccine era].
11 auth.
F. Pumarola,
Ignacio Salamanca de la Cueva,
Alessandra Sistiaga-Hernando,
P. García-Corbeira,
F. Moraga-Llop,
S. Cardelús,
...
Cynthia McCoig,
Justo Ramón Gómez Martínez,
Rosa Rosell Ferrer,
Jesús Iniesta Turpin,
Raghavendra Devadiga
|
2 |
2016 |
2 🐜
|